Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2015 1
2016 1
2018 4
2019 3
2020 9
2021 5
2022 5
2023 5
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
STAT6-targeting antisense oligonucleotides against solitary fibrous tumor.
Li Y, Mondaza-Hernandez JL, Moura DS, Revenko AS, Tolentino A, Nguyen JT, Tran N, Meyer CA, Merino-Garcia J, Ramos R, Di Lernia D, Martin-Broto J, Hayenga HN, Bleris L. Li Y, et al. Among authors: moura ds. Mol Ther Nucleic Acids. 2024 Feb 15;35(2):102154. doi: 10.1016/j.omtn.2024.102154. eCollection 2024 Jun 11. Mol Ther Nucleic Acids. 2024. PMID: 38511173 Free PMC article.
Circulating TNF-RII, IP-10 and HGF are associated with severity of COVID-19 in oncologic patients.
Carrillo-García J, Lacerenza S, Hindi N, Moura DS, Marquina G, Parra Corral D, Olalla J, María Cano Cano J, Hoyos S, Renshaw M, Mondaza-Hernández JL, Di Lernia D, Casado A, Manzano A, Gutierrez A, Martin-Broto J. Carrillo-García J, et al. Among authors: moura ds. Cytokine. 2024 May;177:156542. doi: 10.1016/j.cyto.2024.156542. Epub 2024 Feb 15. Cytokine. 2024. PMID: 38364458 Free article.
Trabectedin and low-dose radiation therapy in patients with advanced leiomyosarcoma.
Martin-Broto J, Olarte-García A, Fernandéz-Rodríguez R, Ferreira MR, Carrasco-García I, Galvez-Montosa F, Rincon-Perez I, Peinado-Serrano J, Azinovic I, Guzman-Gomez L, Salgado L, Sevillano A, Ortega J, Alvarez C, Gutierrez A, Moura DS, Hindi N. Martin-Broto J, et al. Among authors: moura ds. Ther Adv Med Oncol. 2024 Jan 27;16:17588359231225044. doi: 10.1177/17588359231225044. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38288156 Free PMC article.
Delays in diagnosis and surgery of sarcoma patients during the COVID-19 outbreak in Spain.
Carrillo-García J, Lacerenza S, Hindi N, García IC, Marquina G, Cano Cano JM, Trufero JM, Sevillano Tripero AR, Luis García T, Cuesta Rioboo MJ, Moura DS, Renshaw M, Mondaza-Hernández JL, Di Lernia D, Gutierrez A, Martin-Broto J. Carrillo-García J, et al. Among authors: moura ds. Ther Adv Med Oncol. 2024 Jan 9;16:17588359231220611. doi: 10.1177/17588359231220611. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38205079 Free PMC article.
Antiangiogenics in Malignant Granular Cell Tumors: Review of the Literature.
Torrado C, Camaño M, Hindi N, Ortega J, Sevillano AR, Civantos G, Moura DS, Dimino A, Martín-Broto J. Torrado C, et al. Among authors: moura ds. Cancers (Basel). 2023 Oct 28;15(21):5187. doi: 10.3390/cancers15215187. Cancers (Basel). 2023. PMID: 37958362 Free PMC article. Review.
Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/ CDKN2A.
Martin-Broto J, Martinez-Garcia J, Moura DS, Redondo A, Gutierrez A, Lopez-Pousa A, Martinez-Trufero J, Sevilla I, Diaz-Beveridge R, Solis-Hernandez MP, Carnero A, Perez M, Marcilla D, Garcia-Foncillas J, Romero P, Fernandez-Jara J, Lopez-Lopez D, Arribas I, Hindi N. Martin-Broto J, et al. Among authors: moura ds. Signal Transduct Target Ther. 2023 Oct 25;8(1):405. doi: 10.1038/s41392-023-01661-8. Signal Transduct Target Ther. 2023. PMID: 37875500 Free PMC article. Clinical Trial.
REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial.
Martin-Broto J, Valverde C, Hindi N, Vincenzi B, Martinez-Trufero J, Grignani G, Italiano A, Lavernia J, Vallejo A, Tos PD, Le Loarer F, Gonzalez-Campora R, Ramos R, Hernández-Jover D, Gutierrez A, Serrano C, Monteagudo M, Letón R, Robledo M, Moura DS, Martin-Ruiz M, López-Guerrero JA, Cruz J, Fernandez-Serra A, Blay JY, Fumagalli E, Martinez-Marin V. Martin-Broto J, et al. Among authors: moura ds. Mol Cancer. 2023 Aug 9;22(1):127. doi: 10.1186/s12943-023-01832-9. Mol Cancer. 2023. PMID: 37559050 Free PMC article. Clinical Trial.
38 results